Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 12/20 | 0.53 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21671071 | 1.00 | GBA1 (0.53) | GBA1HRH4HRH3EPHX2CYP19A1 | |
| SCHEMBL3533255 | 1.00 | GBA1 (0.53) | GBA1HRH4HRH3EPHX2CYP19A1 | |
| SCHEMBL18391502 | 0.98 | GBA1 (0.51) | GBA1HRH4HRH3EPHX2CYP19A1 | |
| SCHEMBL18489275 | 0.96 | HRH4 (0.56) | GBA1HRH4HRH3EPHX2CYP19A1 | |
| SCHEMBL22762136 | 0.96 | HRH4 (0.56) | GBA1HRH4HRH3EPHX2CYP19A1 | |
| SCHEMBL19300362 | 0.96 | HRH4 (0.56) | GBA1HRH4HRH3EPHX2CYP19A1 | |
| SCHEMBL18493347 | 0.96 | HRH4 (0.56) | GBA1HRH4HRH3EPHX2CYP19A1 | |
| SCHEMBL18494157 | 0.96 | HRH4 (0.56) | GBA1HRH4HRH3EPHX2CYP19A1 | |
| SCHEMBL19479091 | 0.96 | HRH4 (0.56) | GBA1HRH4HRH3EPHX2CYP19A1 | |
| SCHEMBL5021139 | 0.94 | HRH4 (0.54) | GBA1HRH4HRH3EPHX2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317521-A1 | TAGGED NUCLEOTIDES USEFUL FOR NANOPORE DETECTION | Roche Sequencing Solutions, Inc. (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317521-A1 | TAGGED NUCLEOTIDES USEFUL FOR NANOPORE DETECTION | PHAX, POLRMT, POLN | GBA1 3370/4885HRH4 4300/4885HRH3 3737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.